Azenta (AZTA) Stock Forecast & Price Target

Azenta Inc demonstrated a positive financial performance, highlighted by an adjusted EBITDA margin of 13.0%, which reflects a year-over-year increase of 230 basis points and surpasses market consensus. The company anticipates a gross margin improvement of approximately 200 basis points, alongside an operational expense leverage contributing around 100 basis points, further suggesting a trajectory towards enhanced profitability. With the addition of 20 commercial representatives and a robust growth outlook driven by the Multiomics and Sample Management Solutions segments, Azenta is positioned for strong earnings growth and continued margin expansion in the coming years.

Azenta Inc. reported an adjusted gross margin of 46.7%, falling short of consensus expectations and reflecting a decline due to lower margins in its Multiomics segment, despite improvements in the Sample Management Solutions (SMS) product mix. Revenue growth is anticipated to be sluggish, with management projecting a decline of 1-2% year-over-year, heavily influenced by reduced customer budgets and external factors such as the U.S. government shutdown. Consequently, revenue estimates for fiscal years 2026 and 2027 have been revised downward, indicating continued challenges in achieving substantial growth and potential margin contraction within its operations.